Related Experiment Videos
BALB-cfR3: a new high mammary-tumor and high leukemia mouse strain
Journal of the National Cancer Institute
|May 1, 1974
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A population survival model for breast cancer.
Breast (Edinburgh, Scotland)·2005
Hodgkin's lymphoma: the pathologist's viewpoint.
Journal of clinical pathology·2002
Clear cell adenocarcinoma of the vulva arising in endometriosis. A case report.
European journal of gynaecological oncology·2000
Pyothorax-associated lymphoma: description of the first two cases detected in Italy.
Annals of oncology : official journal of the European Society for Medical Oncology·1998
Fine needle aspiration biopsy of salivary gland, 1985-1995.
Acta cytologica·1997
Cancer incidence trends among Asian American, Native Hawaiian, and Pacific Islander populations in the United States, 2000-2022.
Journal of the National Cancer Institute·2026
Psychological distress in adult patients with colorectal cancer: roles of biological age and neighborhood deprivation.
Journal of the National Cancer Institute·2026
A phase II randomized study of proton therapy vs intensity-modulated radiation therapy in patients with unilateral head and neck cancer.
Journal of the National Cancer Institute·2026
Cancer rarity and mortality: Evidence from a nationwide cohort study.
Journal of the National Cancer Institute·2026
Matched targeted therapy use after broad genomic profiling in advanced Non-Small cell lung cancer.
Journal of the National Cancer Institute·2026
Evaluating the incidence and predictors of chronic opioid use in early survivorship for patients with diffuse large B-cell lymphoma.
Journal of the National Cancer Institute·2026
Follicular lymphoma and the microenvironment: potential targets and biomarkers.
Expert review of clinical immunology·2026
Targeting the HEC1-NEK2 Axis Suppresses DLBCL Progression and Overcomes Vincristine Resistance.
Molecular cancer therapeutics·2026
Bufalin Inhibits Melanoma Progression and Endothelial Angiogenic Phenotypes via AKT Signaling.
Cancer reports (Hoboken, N.J.)·2026